entertainment -WSS

entertainment

author：comprehensive 2025-10-01 00:46:16 - browse：495

Adobe

Some of the country’s biggest health insurers said Tuesday that up to one-quarter of their claims are run through Change Healthcare, UnitedHealth Group’s technology company that sustained a massive cyberattack two weeks ago.

Speaking at investor conferences, executives from Humana, Elevance Health, and CVS Health, which owns Aetna, said the biggest impact they’re seeing is fewer bills coming in from providers. For insurers, that means less visibility into how much they’ll have to pay for their members’ medical care in the beginning of the year, although they noted that providers and pharmacies have adopted workarounds that are helping the situation.

“This past weekend we saw a significant increase in activity levels relative to recent years, which suggests in large part that providers are catching up their submissions,” Mark Kaye, Elevance’s chief financial officer, said at TD Cowen’s annual health care conference. Elevance was previously Anthem.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Extensive review finds private equity owners jack up cost of care

WSS

A new nitrogen execution bill also undermines medical licensing

Antivenom research: Lessons from HIV applied in search for universal antidote

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

R1 RCM gets $5.8 billion buyout offer from private equity firm

Scientists grapple with ethics of stem cell research

knowledge

entertainment

knowledge

What does generative AI mean for health care? We asked experts

Alabama hospital puts IVF treatments on hold

Wildfire smoke exposes gaps in outdoor worker protections

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Ed Silverman on new gene therapies, biosimilars, coffee, and more

Activists slam private health insurers over coverage restrictions

Sanders wants to replace patents with prizes for drug inventions

How one medical school became remarkably diverse

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

entertainment

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

Community Health Systems hospitals under DOJ investigation

Sanders wants to replace patents with prizes for drug inventions

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

hotspot

hotspot

entertainment

focus